The Potential of Chondroitin Sulfate as a Therapeutic Agent

REFERENCES

• Iozzo R.V. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 1997; 32(2)141–174
   PubMed Web of Science ®Google Scholar
• Trowbridge J.M., Gallo R.L. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 2002; 12(9)117R–25R
   PubMed Web of Science ®Google Scholar
• Hathcock J.N., Shao A. Risk assessment for glucosamine and chondroitin sulfate. Regul. Toxicol. Pharmacol. 2007; 47(1)78–83
   PubMed Web of Science ®Google Scholar
• Lamari F.N., Karamanos N.K. Structure of chondroitin sulfate. Chondroitin Sulfate: Structure, Role and Pharmacological Activity, N. Volpi. Academic Press, San Diego, CA 2006; 33–48
   Google Scholar
• Vynios D.H., Karamanos N.K., Tsiganos C.P. Advances in analysis of glycosaminoglycans: its application for the assessment of physiological and pathological states of connective tissues. J. Chromatogr B 2002; 781(1–2)21–38
   PubMed Web of Science ®Google Scholar
• Takagaki K., Munakata H., Kakizaki I., Iwafune M., Itabashi T., Endo M. Domain structure of chondroitin sulfate E octasaccharides binding to type V collagen. J. Biol. Chem. 2002; 277(11)8882–8889
   PubMed Web of Science ®Google Scholar
• Maimone M.M., Tollefsen D.M. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. J. Biol. Chem. 1991; 266(22)14830
   PubMed Web of Science ®Google Scholar
• Desaire H., Sirich T.L., Leary J.A. Evidence of block and randomly sequenced chondroitin polysaccharides: sequential enzymatic digestion and quantification using ion trap tandem mass spectrometry. Anal. Chem. 2001; 73(15)3513–3520
   PubMed Web of Science ®Google Scholar
• Mitropoulou T.N., Lamari F., Syrokou A., Hjerpe A., Karamanos N.K. Identification of oligomeric domains within dermatan sulfate chains using differential enzymic treatments, derivatization with 2-aminoacridone and capillary electrophoresis. Electrophoresis 2001; 22(12)2458–2463.
   PubMed Web of Science ®Google Scholar
• Adebowale A.O., Cox D.S., Liang Z., Eddington N.D. Analysis of glucosamine and chondroitin sulfate content in marketed products and the Caco-2 permeability of chondroitin sulfate raw materials. JANA 2000; 3(1)37–44
   Google Scholar
• Sim J.S., Jun G., Toida T., Cho S.Y., Choi D.W., Chang S.Y., Linhardt R.J., Kim Y.S. Quantitative analysis of chondroitin sulphate in raw materials, ophthalmic solutions, soft capsules and liquid preparations. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2005; 818(2)133–139
   PubMed Web of Science ®Google Scholar
• Barnhill J.G., Fye C.L., Williams D.W., Reda D.J., Harris C.L., Clegg D.O. Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial. J. Am. Pharm. Assoc. 2006; 46: 14–24
   Google Scholar
• Saad O.M., Myers R.A., Castleton D.L., Leary J.A. Analysis of hyaluronan content in chondroitin sulfate preparations by using selective enzymatic digestion and electrospray ionization mass spectrometry. Anal. Biochem. 2005; 344: 232–239
   PubMed Web of Science ®Google Scholar
• Malavaki C.J., Asimakopoulou A.P., Lamari F.N., Theocharis A.D., Tzanakakis G., Karamanos N.K. Capillary electrophoresis for the quality control of chondroitin sulfates in raw materials and formulations. Anal. Biochem. 2007; 374: 213–220
   PubMed Web of Science ®Google Scholar
• Lamari F.N., Theocharis A.D., Asimakopoulou A.P., Malavaki C.J., Karamanos N.K. Metabolism and biochemical /physiological roles of chondroitin sulfates: analysis of endogenous and supplemental chondroitin sulfates in blood circulation. Biomed. Chromatogr. 2006; 20(6–7)539–550
   PubMed Web of Science ®Google Scholar
• Adebowale A., Du J., Liang Z., Leslie J.L., Eddington N.D. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm. Drug Dispos. 2002; 23(6)217–225
   PubMed Web of Science ®Google Scholar
• Volpi N. Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers. Osteoarthr. Cart. 2002; 10(10)768–777
   PubMed Web of Science ®Google Scholar
• Volpi N. Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers. Osteoarthr. Cart. 2003; 11(6)433–441
   PubMed Web of Science ®Google Scholar
• Palmieri L., Conte A., Giovannini L., Lualdi P., Ronca G. Metabolic fate of exogenous chondroitin sulfate in the experimental animal. Arzneimittelforschung 1990; 40(3)319–323
   PubMed Web of Science ®Google Scholar
• Ronca F., Palmieri L., Panicucci P., Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthr. Cart. 1998; 6(Suppl A)14–21
   PubMed Web of Science ®Google Scholar
• Pecly I.M.D., Melo-Fihlo N.M., Mourao P.A.S. Effects of molecular size and chemical structure on renal and hepatic removal of exogenously administered chondroitin sulfate in rats. Biochem. Biophys. Acta. 2006; 1760: 865–876
   PubMed Web of Science ®Google Scholar
• Harris E.N., Kyosseva S.V., Weigel J.A., Weigel P.H. Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE). J. Biol. Chem. 2007; 282(5)2785–2795
   PubMed Web of Science ®Google Scholar
• Bruyere O., Reginster J.-Y. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs. Aging 2007; 24(7)573–580
   PubMed Web of Science ®Google Scholar
• McAlindon T.E., LaValley M.P., Gulin J.P., Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and metaanalysis. JAMA. 2000; 283: 1469–1475
   PubMed Web of Science ®Google Scholar
• Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O'Dell J.R., Hooper M.M., Bradley J.D., Bingham C.O. 3rd, Weisman M.H., Jackson C.G., Lane N.E., Cush J.J., Moreland L.W., Schumacher H.R. Jr., Oddis C.V., Wolfe F., Molitor J.A., Yocum D.E., Schnitzer T.J., Furst D.E., Sawitzke A.D., Shi H., Brandt K.D., Moskowitz R.W., Williams H.J. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N. Engl. J. Med. 2006; 354(8)795–808
   PubMed Web of Science ®Google Scholar
• Messier S.P., Mihalko S., Loeser R.F., Legault C., Jolla J., Pfruender J., Prosser B., Adrian A., Williamson J.D. Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis: a preliminary study. Osteoarthr. Cart. 2007, in press
   PubMed Web of Science ®Google Scholar
• Mazières B., Hucher M., Zaïm M., Garnero P. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Ann. Rheum. Dis. 2007; 66(5)639–645
   PubMed Web of Science ®Google Scholar
• Bjordal J.M., Klovning A., Ljunggren A.E., Slordal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur. J. Pain 2007; 11: 125–138
   PubMed Web of Science ®Google Scholar
• Reichenbach S., Sterchi R., Scherer M., Trelle S., Burgi E., Burgi U., Dieppe P.A., Juni P. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann. Intern. Med. 2007; 146: 580–590
   PubMed Web of Science ®Google Scholar
• Michel B.A., Stucki G., Frey D., De Vathaire F., Vignon E., Bruehlmann P., Uebelhart D. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthr. Rheum. 2005; 52(3)7790–786
   Web of Science ®Google Scholar
• Vergés J., Montell E., Herrero M., Perna C., Cuevas J., Pérez M., Möller I. Clinical and histopathological improvement of psoriasis with oral chondroitin sulfate: a serendipitous finding. Dermatol. Online J. 2005; 11(1)31
   PubMedGoogle Scholar
• Theoharides T.C., Sant G.R. A pilot open label study of Cystoprotek in interstitial cystitis. Int J. Immunopathol. Pharmacol. 2005; 18(1)183–188
   PubMed Web of Science ®Google Scholar
• Steinhoff G., Ittah B., Rowan S. The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can. J. Urol. 2002; 9(1)1454–1458
   PubMedGoogle Scholar
• Fioravanti A., Collodel G. Structure of chondroitin sulfate. Chondroitin sulfate: Structure, Role and Pharmacological Activity, N. Volpi. Academic Press, San Diego, CA 2006; 449–465
   Google Scholar
• Campo G.M., Avenoso A., Campo S., Ferlazzo A.M., Calatroni A. Antioxidant activity of chondroitin sulfate. Chondroitin sulfate: Structure, Role and Pharmacological Activity, N. Volpi. Academic Press, San Diego, CA 2006; 417–431
   Google Scholar
• Toida T., Sakai S., Akiyama H., Linhardt R.J. Immunological activity of chondroitin sulfate. Chondroitin sulfate: Structure, Role and Pharmacological Activity, N. Volpi. Academic Press, San Diego, CA 2006; 403–415
   Google Scholar
• Legendre F., Baugé C., Roche R., Saurel A.S., Pujol J.P. Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1beta-stimulated chondrocytes—study in hypoxic alginate bead cultures. Osteoarthr. Cart. 2007; 16(1)105–114
   PubMed Web of Science ®Google Scholar